Skin toxicity and quality of life in patients with metastatic colorectal cancer during first-line panitumumab plus FOLFIRI treatment in a single-arm phase II study. Veröffentlicht vonadmin 27. Juli 2020 Thaler J, Karthaus M, Mineur L, Greil R, Letocha H, Hofheinz R, Fernebro E, Gamelin E, BaГѓВ±os A, KГ¶hne CH. http://www.ncbi.nlm.nih.gov/pubmed/23020584